Correlation Between Pmv Pharmaceuticals and ProMIS Neurosciences
Can any of the company-specific risk be diversified away by investing in both Pmv Pharmaceuticals and ProMIS Neurosciences at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Pmv Pharmaceuticals and ProMIS Neurosciences into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Pmv Pharmaceuticals and ProMIS Neurosciences, you can compare the effects of market volatilities on Pmv Pharmaceuticals and ProMIS Neurosciences and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Pmv Pharmaceuticals with a short position of ProMIS Neurosciences. Check out your portfolio center. Please also check ongoing floating volatility patterns of Pmv Pharmaceuticals and ProMIS Neurosciences.
Diversification Opportunities for Pmv Pharmaceuticals and ProMIS Neurosciences
-0.54 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between Pmv and ProMIS is -0.54. Overlapping area represents the amount of risk that can be diversified away by holding Pmv Pharmaceuticals and ProMIS Neurosciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on ProMIS Neurosciences and Pmv Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Pmv Pharmaceuticals are associated (or correlated) with ProMIS Neurosciences. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of ProMIS Neurosciences has no effect on the direction of Pmv Pharmaceuticals i.e., Pmv Pharmaceuticals and ProMIS Neurosciences go up and down completely randomly.
Pair Corralation between Pmv Pharmaceuticals and ProMIS Neurosciences
Given the investment horizon of 90 days Pmv Pharmaceuticals is expected to generate 0.52 times more return on investment than ProMIS Neurosciences. However, Pmv Pharmaceuticals is 1.91 times less risky than ProMIS Neurosciences. It trades about 0.0 of its potential returns per unit of risk. ProMIS Neurosciences is currently generating about -0.29 per unit of risk. If you would invest 163.00 in Pmv Pharmaceuticals on September 1, 2024 and sell it today you would lose (1.00) from holding Pmv Pharmaceuticals or give up 0.61% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Pmv Pharmaceuticals vs. ProMIS Neurosciences
Performance |
| Timeline |
| Pmv Pharmaceuticals |
| ProMIS Neurosciences |
Pmv Pharmaceuticals and ProMIS Neurosciences Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Pmv Pharmaceuticals and ProMIS Neurosciences
The main advantage of trading using opposite Pmv Pharmaceuticals and ProMIS Neurosciences positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Pmv Pharmaceuticals position performs unexpectedly, ProMIS Neurosciences can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in ProMIS Neurosciences will offset losses from the drop in ProMIS Neurosciences' long position.| Pmv Pharmaceuticals vs. Tff Pharmaceuticals | Pmv Pharmaceuticals vs. Eliem Therapeutics | Pmv Pharmaceuticals vs. Inhibrx | Pmv Pharmaceuticals vs. Enliven Therapeutics |
| ProMIS Neurosciences vs. Tff Pharmaceuticals | ProMIS Neurosciences vs. Eliem Therapeutics | ProMIS Neurosciences vs. Inhibrx | ProMIS Neurosciences vs. Enliven Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sign In To Macroaxis module to sign in to explore Macroaxis' wealth optimization platform and fintech modules.
Other Complementary Tools
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios |